Exceptional Response to Pembrolizumab in a Patient With Castration-Resistant Prostate Cancer With Pancytopenia From Myelophthisis.

TitleExceptional Response to Pembrolizumab in a Patient With Castration-Resistant Prostate Cancer With Pancytopenia From Myelophthisis.
Publication TypeJournal Article
Year of Publication2019
AuthorsVlachostergios PJ, Geyer JT, Miller J, Kosloff R, Beltran H, Tagawa ST
JournalJ Oncol Pract
Volume15
Issue6
Pagination343-345
Date Published2019 06
ISSN1935-469X
KeywordsAged, Anemia, Myelophthisic, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, Bone Neoplasms, Humans, Male, Pancytopenia, Prognosis, Prostatic Neoplasms, Castration-Resistant
DOI10.1200/JOP.19.00012
Alternate JournalJ Oncol Pract
PubMed ID30964731
Related Faculty: 
Julia Geyer, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700